abstract |
The present invention relates to the use of a progesterone receptor antagonist, namely (11?, 17?) -17-hydroxy-11- [4- (methylsulfonyl) phenyl] -17- (pentafluoro- (Myoma, uterine leiomyoma) comprising estra-4,9-dien-3-one. In addition, the present invention provides methods of treating uterine fibroids (myoma, uterine leiomyoma) and / or reducing symptoms associated with uterine fibroids (myoma, uterine leiomyoma) and uterine fibroids, as well as methods of treating hypermenorrhea (HMB) . |